HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cleavage of desmoglein 3 can explain its depletion from keratinocytes in pemphigus vulgaris.

AbstractWe have previously demonstrated that serum of patients with pemphigus vulgaris induces reduction of desmoglein 3 (Dsg3) half-life in keratinocytes (FEBS Lett 2006: 580: 3276). This phenomenon seems to occur as a consequence of the progressive depletion of Dsg3 from desmosomes. Here we reported that reduction of full-length Dsg3 may be due to its progressive cleavage, leading to the formation of two fragmentation products with apparent molecular masses of about 60 kDa (fragment 1) and 70 kDa (fragment 2), as revealed by Western blotting. Unexpectedly, analysis of fragmentation pattern suggested cleavage to occur intracellularly. Consistently, fragment 1 was shed and localized within the cytosol, as shown by living cell immunofluorescence microscopy. Total amounts of full-length plakoglobin and Dsg1 were apparently unchanged. Taken together, our findings provide evidence that proteolytic processing of Dsg3 can lead to depletion of Dsg3 from the cell.
AuthorsNicola Cirillo, Giuseppina Campisi, Fernando Gombos, Letizia Perillo, Felice Femiano, Alessandro Lanza (Affiliation: Regional Center on Craniofacial Malformations-MRI, First School of Medicine and Surgery, Second University of Naples, Naples, Italy. cirillo.sun at libero.it)
JournalExperimental dermatology (Exp Dermatol) Vol. 17 Issue 10 Pg. 858-63 (Oct 2008) ISSN: 1600-0625 [Electronic] Denmark
PMID18505410 (Publication Type: Journal Article)
Chemical References
  • Blood Proteins
  • DSG1 protein, human
  • DSG3 protein, human
  • Desmoglein 1
  • Desmoglein 3
  • Desmoplakins
  • JUP protein, human
Topics
  • Blood Proteins (pharmacology)
  • Blotting, Western
  • Cell Line
  • Desmoglein 1 (metabolism)
  • Desmoglein 3 (metabolism)
  • Desmoplakins (metabolism)
  • Humans
  • Keratinocytes (metabolism, pathology)
  • Pemphigus (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD